Loading...
XNASTRNS
Market cap953mUSD
Jan 13, Last price  
103.49USD
1D
-3.19%
1Q
-18.90%
Jan 2017
850.00%
Name

Transcat Inc

Chart & Performance

D1W1MN
XNAS:TRNS chart
P/E
70.49
P/S
3.71
EPS
1.47
Div Yield, %
0.00%
Shrs. gr., 5y
2.13%
Rev. gr., 5y
10.03%
Revenues
259m
+12.54%
55,307,00060,471,00066,473,00070,453,00075,419,00081,061,00091,186,000110,020,000112,296,000118,508,000123,624,000122,166,000143,898,000155,141,000160,898,000173,099,000173,335,000204,959,000230,569,000259,481,000
Net income
14m
+27.69%
256,0003,577,0002,059,0002,363,0001,556,0001,451,0002,788,0003,302,0003,704,0003,984,0004,026,0004,124,0004,522,0005,922,0007,145,0008,067,0007,791,00011,380,00010,688,00013,647,000
CFO
33m
+92.41%
-6,0004,435,0002,645,0003,593,0003,816,0005,649,0002,573,0006,259,0005,241,0007,612,0004,439,00010,982,0007,544,0009,874,00012,561,00011,561,00023,639,00017,618,00016,951,00032,616,000
Earnings
Jan 27, 2025

Profile

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management software that is used to integrate and manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.
IPO date
Jul 05, 1965
Employees
1,030
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
259,481
12.54%
230,569
12.50%
204,959
18.24%
Cost of revenue
239,700
214,321
190,816
Unusual Expense (Income)
NOPBT
19,781
16,248
14,143
NOPBT Margin
7.62%
7.05%
6.90%
Operating Taxes
4,792
2,799
1,810
Tax Rate
24.23%
17.23%
12.80%
NOPAT
14,989
13,449
12,333
Net income
13,647
27.69%
10,688
-6.08%
11,380
46.07%
Dividends
Dividend yield
Proceeds from repurchase of equity
72,360
211
(5,197)
BB yield
-7.78%
-0.03%
0.92%
Debt
Debt current
4,849
2,248
2,161
Long-term debt
34,073
72,789
64,679
Deferred revenue
Other long-term liabilities
2,903
1,434
1,667
Net debt
3,643
73,306
65,244
Cash flow
Cash from operating activities
32,616
16,951
17,618
CAPEX
(13,280)
(9,414)
(10,152)
Cash from investing activities
(41,672)
(18,513)
(39,851)
Cash from financing activities
27,399
876
23,694
FCF
(1,095)
(265)
(1,003)
Balance
Cash
35,179
1,531
1,396
Long term investments
100
200
200
Excess cash
22,305
Stockholders' equity
83,545
71,744
62,276
Invested Capital
227,306
162,405
145,489
ROIC
7.69%
8.74%
9.83%
ROCE
7.64%
9.62%
9.29%
EV
Common stock shares outstanding
8,352
7,645
7,589
Price
111.43
28.39%
86.79
16.95%
74.21
39.57%
Market cap
930,663
40.26%
663,510
17.81%
563,180
40.33%
EV
934,306
736,816
628,424
EBITDA
33,325
27,203
23,710
EV/EBITDA
28.04
27.09
26.50
Interest
1,835
2,761
953
Interest/NOPBT
9.28%
16.99%
6.74%